Publications by authors named "Kate Rochlin"

Claim this Profile
T
Temozolomide and the PARP Inhibitor Niraparib Enhance Expression of Natural Killer Group 2D Ligand ULBP1 and Gamma-Delta T Cell Cytotoxicity in Glioblastoma.
Amber B Jones, Kaysaw Tuy, Cyntanna C Hawkins, Colin H Quinn, Joelle Saad, Kate M Rochlin

Cancers (Basel)· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral mucosal immunotherapy for allergic rhinitis: A pilot study.
William R Reisacher, Maria V Suurna, Kate Rochlin, Maria G Bremberg, Guy Tropper

Allergy Rhinol (Providence)· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myoblast fusion: when it takes more to make one.
Kate Rochlin, Shannon Yu, Sudipto Roy, Mary K Baylies

Dev Biol· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression and functional analysis of a novel Fusion Competent Myoblast specific GAL4 driver.
Karen Beckett, Kate M Rochlin, Hong Duan, Hanh T Nguyen, Mary K Baylies

Gene Expr Patterns· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endocytic trafficking of Wingless and its receptors, Arrow and DFrizzled-2, in the Drosophila wing.
Anna F Rives, Kate M Rochlin, Marcel Wehrli, Stephanie L Schwartz, Stephen DiNardo

Dev Biol· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis